References
- Cucinotta D, Vanelli M. Who declares COVID-19 a pandemic. Acta Biomed. 2020;91:157–160. doi:10.23750/abm.v91i1.9397
- Sigorski D, Sobczuk P, Osmola M, et al. Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy. ESMO Open. 2020;5(5):e000970. doi:10.1136/esmoopen-2020-000970
- WHO. Mental health and psychosocial considerations during the COVID-19 outbreak; 2020. Available from: https://apps.who.int/iris/handle/10665/331490. Accessed July 1, 2020.
- Taylor MR, Agho KE, Stevens GJ, et al. Factors influencing psychological distress during a disease epidemic: data from Australia’s first outbreak of equine influenza. BMC Public Health. 2008;8(1):347. doi:10.1186/1471-2458-8-347
- Tucci V, Moukaddam N, Meadows J, et al. The forgotten plague: psychiatric manifestations of Ebola, Zika, and emerging infectious diseases. J Glob Infect Dis. 2017;9(4):151–156. doi:10.4103/jgid.jgid_66_17
- Soares RS, Mellen P, Garrigan H, et al. Outcomes of eyes lost to follow-up with neovascular age-related macular degeneration receiving intravitreal anti-vascular endothelial growth factor. Ophthalmol Retina. 2020;4(2):134–140. doi:10.1016/j.oret.2019.07.010
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
- Hu VH, Watts E, Burton M, et al. Protecting yourself and your patients from COVID-19 in eye care. Community Eye Health. 2020;33(108):S1–S6.
- Borrelli E, Grosso D, Vella G, et al. Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”. Graefes Arch Clin Exp Ophthalmol. 2020;258(12):2655–2660. doi:10.1007/s00417-020-04858-7
- Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict. 2020;27:1–9.
- Hinkle DE, Wiersma W, Jurs SG. Applied Statistics for the Behavioral Sciences. 3rd ed. Houghton Mifflin: Boston; 1994.
- Reznik A, Gritsenko V, Konstantinov V, et al. COVID-19 fear in eastern Europe: validation of the fear of COVID-19 scale. Int J Ment Health Addict. 2020;1–6.
- Soraci P, Ferrari A, Abbiati FA. et al. Validation and psychometric evaluation of the Italian version of the fear of COVID-19 scale. Int J Ment Health Addict;2020. 1–10. doi:10.1007/s11469-020-00277-1
- Evren C, Evren B, Dalbudak E, et al. Measuring anxiety related to COVID-19: a Turkish validation study of the coronavirus anxiety scale. Death Stud. 2020:1–7. doi:10.1080/07481187.2020.1774969
- Caycho-Rodríguez T, Vilca LW, Cervigni M, et al. Fear of COVID-19 scale: validity, reliability and factorial invariance in Argentina’s general population. Death Stud. 2020;29:1–10. doi:10.1080/07481187.2020.1836071
- Université Laval. Quebec: Quebec and the world; 2020. Available from: https://ulaval.maps.arcgis.com/apps/opsdashboard/index.html#/05990238bd6a4734b2d544e3143e57a7. Accessed December 7, 2020.
- Bodas M, Siman-Tov M, Peleg K, et al. Anxiety-Inducing media: the effect of constant news broadcasting on the well-being of Israeli television viewers. Psychiatry. 2015;78:265–276. doi:10.1080/00332747.2015.1069658
- de Hoog N, Verboon P. Is the news making us unhappy? The influence of daily news exposure on emotional states. Br J Psychol. 2020;111:157–173. doi:10.1111/bjop.12389
- Fung THM, Kuet ML, Patel MK, Puri P. Addressing COVID-19 fear to improve clinic attendance for patients with wet age related macular degeneration. Acta Ophthalmol. 2020. doi:10.1111/aos.14520